PODD
Insulet Corporation
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Sell
-27/100
Last price
134.93
▼ 0.69 (0.51%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
135.00
Prev close
135.62
Day high
136.16
Day low
133.73
Volume
1.71M
Market cap
$9.34B
P/E (TTM)
25.42
52W range
126.40 – 354.88
Day trading desk
Gap from prior close
-0.46%
Prior close 135.62
VWAP
134.93
+0.00% from price
Relative volume
1.21×
Normal
Session range
8.37%
129.00 – 139.80
Position in range
55%
Mid range
ATR (14D)
3.76
2.78% of price
Prior day high
135.81
PDH
Prior day low
131.23
PDL
Bid / ask spread
—
Quote not published
Session volume
2.02M
Avg 1.68M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.42%
-0.5%
1M
-8.65%
-9.8%
3M
-14.44%
-19.0%
6M
-33.45%
-51.6%
YTD
-52.60%
-66.8%
1Y
-56.41%
-72.8%
3Y
-15.52%
-97.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PODD open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+20.75K
Net buying
Buy transactions
13
21.17K shares
Sell transactions
1
418 shares
Net transactions
+14
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
228.87K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 1, 26 | MAZELSKY JONATHAN JAY Director |
STOCK | 1.35K | $0 | Direct |
| Jun 30, 26 | HUFFINES ROBERT LUTHER Director |
STOCK | 144 | $23.01K | Direct |
| Jun 30, 26 | HUFFINES ROBERT LUTHER Director |
STOCK | 151 | $22.99K | Direct |
| Jun 3, 26 | BORIO LUCIANA Director |
SELL | 418 | $59.89K | Direct |
| Jun 3, 26 | STONESIFER TIMOTHY C Director |
BUY | 2.79K | $400.39K | Direct |
| Jun 3, 26 | WEATHERMAN ELIZABETH H Director |
BUY | 3.45K | $497.49K | Direct |
| May 20, 26 | SCANNELL TIMOTHY J. Director |
STOCK | 1.66K | $0 | Direct |
| May 20, 26 | WEATHERMAN ELIZABETH H Director |
STOCK | 1.66K | $0 | Direct |
| May 20, 26 | HOPFIELD JESSICA Director |
STOCK | 1.66K | $0 | Direct |
| May 20, 26 | STONESIFER TIMOTHY C Director |
STOCK | 1.66K | $0 | Direct |
| May 20, 26 | MINOGUE MICHAEL R Director |
STOCK | 1.66K | $0 | Direct |
| May 20, 26 | HUFFINES ROBERT LUTHER Director |
STOCK | 1.66K | $0 | Direct |
| May 20, 26 | FREDERICK WAYNE A.I. Director |
STOCK | 1.66K | $0 | Direct |
| May 20, 26 | BORIO LUCIANA Director |
STOCK | 1.66K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BENJAMIN ERIC |
Chief Operating Officer | 24.51K | Stock Award(Grant) |
CHADWICK ANA MARIA |
Chief Financial Officer | 16.03K | Stock Award(Grant) |
FIELD MARK N |
Chief Technology Officer | 13.91K | Stock Award(Grant) |
HOLLINGSHEAD JAMES R |
Chief Executive Officer | 68.07K | Stock Award(Grant) |
HOPFIELD JESSICA |
Director | 29.36K | Stock Award(Grant) |
KAPPLES JOHN W. |
General Counsel | 28.12K | Stock Award(Grant) |
MCEVOY ASHLEY |
Chief Executive Officer | 23.97K | Stock Award(Grant) |
MINOGUE MICHAEL R |
Director | 19.92K | Stock Award(Grant) |
PEASE FLAVIA H. |
Chief Financial Officer | 19.16K | Stock Award(Grant) |
SCANNELL TIMOTHY J. |
Director | 33.02K | Stock Award(Grant) |
Fundamentals
Market cap$9.34B
Enterprise value$9.76B
Revenue (TTM)$3.05B
Gross profit$2.17B
EBITDA$614.90M
Net income$375.30M
EPS (TTM)$5.30
Free cash flow$236.90M
Total cash$534.90M
Total debt$948.40M
Book value / share$20.51
Shares outstanding69.35M
Float69.06M
Short % of float8.27%
Dividend yield0.00%
Beta (5Y)1.10
Valuation & profitability ratios
Trailing P/E25.42
Forward P/E17.43
PEG ratio1.07
Price / sales—
Price / book6.57
EV / revenue3.20
EV / EBITDA15.87
Gross margin71.08%
Operating margin16.18%
Profit margin12.29%
Return on equity26.02%
Return on assets9.71%
Debt / equity66.69
Current ratio2.49
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.71B | $2.07B | $1.70B | $1.31B | +30.7% |
| Operating revenue | $2.71B | $2.07B | $1.70B | $1.31B | +30.7% |
| Cost of revenue | $768.20M | $625.90M | $537.20M | $499.70M | +22.7% |
| Gross profit | $1.94B | $1.45B | $1.16B | $805.60M | +34.2% |
| Research & development | $301.10M | $219.60M | $205.00M | $180.20M | +37.1% |
| Selling, general & admin | $1.17B | $917.20M | $734.80M | $587.80M | +27.0% |
| Total operating expense | $1.47B | $1.14B | $939.80M | $768.00M | +29.0% |
| Operating income | $473.80M | $308.90M | $220.10M | $37.60M | +53.4% |
| Net interest income | -$24.70M | -$3.20M | -$7.60M | -$26.70M | -671.9% |
| Pre-tax income | $339.50M | $300.20M | $214.70M | $9.80M | +13.1% |
| Tax provision | $92.40M | -$118.10M | $8.30M | $5.20M | +178.2% |
| Net income | $247.10M | $418.30M | $206.30M | $4.60M | -40.9% |
| Net income to common | $247.10M | $418.30M | $206.30M | $4.60M | -40.9% |
| Basic EPS | 3.51 | 5.97 | 2.96 | 0.07 | -41.2% |
| Diluted EPS | 3.48 | 5.78 | 2.94 | 0.07 | -39.8% |
| EBIT | $398.90M | $342.90M | $250.90M | $45.80M | +16.3% |
| EBITDA | $489.30M | $423.70M | $323.70M | $109.00M | +15.5% |
| Basic shares | 70.35M | 70.08M | 69.75M | 69.38M | +0.4% |
| Diluted shares | 71.89M | 73.89M | 73.63M | 69.91M | -2.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $716.10M | $953.30M | $704.20M | $674.20M | -24.9% |
| Cash & short-term investments | $716.10M | $953.30M | $704.20M | $674.20M | -24.9% |
| Accounts receivable | $511.30M | $355.80M | $356.50M | $205.60M | +43.7% |
| Inventory | $452.60M | $430.40M | $402.60M | $346.80M | +5.2% |
| Total current assets | $1.91B | $1.89B | $1.58B | $1.31B | +1.2% |
| Property, plant & equipment | $819.40M | $723.10M | $664.90M | $599.90M | +13.3% |
| Goodwill & intangibles | $168.70M | $150.00M | $150.40M | $127.20M | +12.5% |
| Total assets | $3.19B | $3.09B | $2.59B | $2.25B | +3.3% |
| Total current liabilities | $680.10M | $528.40M | $451.20M | $364.70M | +28.7% |
| Current debt | $18.40M | $83.80M | $49.40M | $27.50M | -78.0% |
| Long-term debt | $930.80M | $1.30B | $1.37B | $1.37B | -28.2% |
| Total debt | $949.20M | $1.38B | $1.42B | $1.40B | -31.2% |
| Total liabilities | $1.68B | $1.88B | $1.86B | $1.77B | -10.7% |
| Retained earnings | $287.40M | $40.30M | -$378.00M | -$584.30M | +613.2% |
| Shareholder equity | $1.52B | $1.21B | $732.70M | $476.40M | +25.1% |
| Working capital | $1.23B | $1.36B | $1.13B | $949.30M | -9.5% |
| Net tangible assets | $1.35B | $1.06B | $582.30M | $349.20M | +26.8% |
| Shares issued | 70.59M | 70.20M | 69.91M | 69.51M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $247.10M | $418.30M | $206.30M | $4.60M | -40.9% |
| Depreciation & amortisation | $90.40M | $80.80M | $72.80M | $63.20M | +11.9% |
| Stock-based compensation | $62.70M | $69.30M | $48.40M | $40.90M | -9.5% |
| Change in working capital | -$23.10M | -$17.00M | -$190.60M | -$2.50M | -35.9% |
| Operating cash flow | $569.30M | $430.20M | $145.70M | $119.00M | +32.3% |
| Capital expenditure | -$219.40M | -$134.00M | -$109.20M | -$157.30M | -63.7% |
| Investing cash flow | -$222.70M | -$146.20M | -$119.40M | -$191.10M | -52.3% |
| Share buybacks | -$59.60M | $0 | $0 | — | — |
| Financing cash flow | -$595.30M | -$28.00M | -$13.60M | -$40.30M | -2,026.1% |
| Free cash flow | $349.90M | $296.20M | $36.50M | -$38.30M | +18.1% |
| End cash position | $716.10M | $953.40M | $704.20M | $689.70M | -24.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $801.70M | $761.70M | $783.80M | $706.30M | $649.10M | +5.3% |
| Operating revenue | $801.70M | $761.70M | $783.80M | $706.30M | $649.10M | +5.3% |
| Cost of revenue | $239.10M | $232.70M | $215.20M | $196.20M | $196.90M | +2.8% |
| Gross profit | $562.60M | $529.10M | $568.60M | $510.10M | $452.20M | +6.3% |
| Research & development | $88.10M | $89.70M | $90.90M | $77.20M | $73.40M | -1.8% |
| Selling, general & admin | $344.80M | $317.20M | $331.40M | $315.20M | $257.70M | +8.7% |
| Total operating expense | $432.90M | $406.90M | $422.30M | $392.40M | $331.10M | +6.4% |
| Operating income | $129.70M | $122.20M | $146.30M | $117.70M | $121.10M | +6.1% |
| Net interest income | -$9.90M | -$9.80M | -$9.20M | -$7.00M | -$9.50M | -1.0% |
| Pre-tax income | $118.70M | $113.00M | $140.20M | $122.80M | $28.40M | +5.0% |
| Tax provision | $23.70M | $21.90M | $38.50M | $35.20M | $5.90M | +8.2% |
| Net income | $95.00M | $91.10M | $101.60M | $87.60M | $22.50M | +4.3% |
| Net income to common | $95.00M | $91.10M | $101.60M | $87.60M | $22.50M | +4.3% |
| Basic EPS | 1.37 | 1.30 | 1.44 | 1.24 | 0.32 | +5.4% |
| Diluted EPS | 1.37 | 1.30 | 1.44 | 1.24 | 0.32 | +5.4% |
| EBIT | $132.20M | $127.70M | $155.10M | $138.40M | $48.00M | +3.5% |
| EBITDA | $158.90M | $153.90M | $179.50M | $160.40M | $70.30M | +3.2% |
| Basic shares | 69.30M | 69.99M | 70.36M | 70.37M | 70.39M | -1.0% |
| Diluted shares | 69.40M | 70.20M | 70.67M | 70.66M | 70.65M | -1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $534.90M | $480.40M | $716.10M | $757.50M | $1.12B | +11.3% |
| Cash & short-term investments | $534.90M | $480.40M | $716.10M | $757.50M | $1.12B | +11.3% |
| Accounts receivable | $580.40M | $542.10M | $511.30M | $453.10M | $430.70M | +7.1% |
| Inventory | $484.80M | $462.50M | $452.60M | $446.30M | $447.00M | +4.8% |
| Total current assets | $1.85B | $1.71B | $1.91B | $1.86B | $2.28B | +8.2% |
| Property, plant & equipment | $858.60M | $830.40M | $819.40M | $724.10M | $720.40M | +3.4% |
| Goodwill & intangibles | $166.60M | $166.90M | $168.70M | $156.80M | $154.00M | -0.2% |
| Total assets | $3.17B | $2.99B | $3.19B | $3.03B | $3.47B | +6.0% |
| Total current liabilities | $744.20M | $687.50M | $680.10M | $647.70M | $1.01B | +8.2% |
| Current debt | $18.90M | $18.60M | $18.40M | $79.90M | $460.70M | +1.6% |
| Long-term debt | $929.50M | $929.50M | $930.80M | $934.90M | $939.00M | 0.0% |
| Total debt | $948.40M | $948.10M | $949.20M | $1.01B | $1.40B | +0.0% |
| Total liabilities | $1.74B | $1.68B | $1.68B | $1.65B | $2.01B | +3.5% |
| Retained earnings | $473.50M | $378.50M | $287.40M | $185.80M | $98.20M | +25.1% |
| Shareholder equity | $1.42B | $1.30B | $1.52B | $1.38B | $1.46B | +9.2% |
| Working capital | $1.10B | $1.02B | $1.23B | $1.21B | $1.27B | +8.1% |
| Net tangible assets | $1.26B | $1.14B | $1.35B | $1.23B | $1.31B | +10.6% |
| Shares issued | 69.35M | 70.71M | 70.59M | 70.53M | 70.48M | -1.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $95.00M | $91.10M | $101.60M | $87.60M | $22.50M | +4.3% |
| Depreciation & amortisation | $26.70M | $26.20M | $24.40M | $22.00M | $22.30M | +1.9% |
| Stock-based compensation | $19.60M | $21.30M | $20.30M | $16.70M | $7.50M | -8.0% |
| Change in working capital | -$62.00M | -$32.40M | $14.50M | -$25.70M | $53.00M | -91.4% |
| Operating cash flow | $88.40M | $113.80M | $183.30M | $125.70M | $196.50M | -22.3% |
| Capital expenditure | -$37.30M | -$27.80M | -$149.40M | -$31.10M | -$23.20M | -34.2% |
| Investing cash flow | -$37.40M | -$27.70M | -$152.80M | -$31.00M | -$23.30M | -35.0% |
| Share buybacks | $0 | -$300.00M | $0 | -$29.50M | -$30.10M | +100.0% |
| Financing cash flow | $4.00M | -$319.90M | -$72.50M | -$457.00M | -$343.50M | +101.3% |
| Free cash flow | $51.10M | $86.00M | $33.90M | $94.60M | $173.30M | -40.6% |
| End cash position | $534.90M | $480.40M | $716.10M | $757.40M | $1.12B | +11.3% |
Options analytics
Put / call volume
1.05
Put-heavy session
Put / call open interest
0.71
Positioning, not flow
Max pain
140.00
+3.9% from spot
ATM implied vol
48.7%
Nearest strike to spot
Skew (10% OTM)
+4.8%
Puts bid over calls
Call volume
56
Contracts, this expiry
Put volume
59
Contracts, this expiry
Heaviest call OI
170.00
462 contracts
Heaviest put OI
145.00
531 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.45 | 1.66 | +14.3% |
| Mar 2026 | 1.19 | 1.42 | +19.3% |
| Dec 2025 | 1.46 | 1.55 | +6.0% |
| Sep 2025 | 1.15 | 1.24 | +8.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.59 | 22 | $833.04M | +17.9% |
| Next quarter | 1.84 | 21 | $893.80M | +14.0% |
| Current year | 6.50 | 23 | $3.29B | +21.4% |
| Next year | 7.70 | 23 | $3.74B | +13.7% |
Analyst targets & ownership
Mean target$171.91
High target$275.00
Low target$144.00
Implied upside27.41%
Analyst count22
ConsensusBUY
Strong buy / Buy4 / 11
Hold10
Sell / Strong sell0 / 0
Held by insiders0.33%
Held by institutions106.98%
Institutions holding1.09K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
133.76
+0.87% from price
SMA 20
136.10
-1.00% from price
SMA 50
144.08
-6.49% from price
SMA 100
149.04
-9.47% from price
SMA 200
191.84
-29.77% from price
EMA 12
134.87
+0.04% from price
EMA 26
138.09
-2.29% from price
EMA 50
143.16
-5.75% from price
RSI (14)
43.1
Neutral
MACD (12,26,9)
-3.22
Hist 0.15
ATR (14)
3.76
2.79% of price
Realised vol 30D
27.9%
Annualised
Bollinger upper
142.98
20, 2σ
Bollinger lower
129.21
20, 2σ
50 / 200 cross
Death
144.08 vs 191.84
Trend bias
Below 200
-29.77%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.29
Less volatile than market
Correlation to SPY
0.09
Largely independent
Realised vol 30D
27.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-62.3%
Peak to trough
Max drawdown 5Y
-63.0%
Peak to trough
ATR 14
3.76
2.79% of price
Beta (reported)
1.10
5Y monthly, from filing
Short interest
Shares short
5.08M
Prior 3.70M
Change vs prior
+37.5%
Shorts adding
% of float
8.27%
Normal
% of shares out
7.33%
Against total outstanding
Days to cover
2.9
Liquid
Float
69.06M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 6, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Leerink Partners | DOWNGRADE | Outperform | Market Perform |
| Aug 6, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Aug 6, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Aug 6, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Bernstein | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Benchmark | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Stifel | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| Aug 6, 26 | JP Morgan | DOWNGRADE | Overweight | Neutral |
| Aug 6, 26 | BTIG | DOWNGRADE | Buy | Neutral |
| Aug 6, 26 | Truist Securities | DOWNGRADE | Buy | Hold |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-21
Corporate Changes & Voting Matters
8-K · 2026-09-16
Corporate Changes & Voting Matters
8-K · 2026-09-10
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-25
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-28
Corporate Changes & Voting Matters
8-K · 2026-05-26
Corporate Changes & Voting Matters
8-K · 2026-05-21
Headlines
2 Safe-and-Steady Stocks to Consider Right Now and 1 Facing Challenges
StockStory · 6d ago
Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026
Business Wire · 6d ago
Insulet Sees Emerging Headwinds From New Market Entrants in 2027, 2028, Oppenheimer Says
MT Newswires · 8d ago
Insulet (PODD) Stock May Trade At A Discount To Fair Value
Simply Wall St. · 11d ago
2 Healthcare Stocks with Impressive Fundamentals and 1 Facing Challenges
StockStory · 11d ago
Insulet (PODD) Reworked Its Debt, Is The Stock Still Cheap?
Simply Wall St. · 12d ago
Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum
MarketBeat · 12d ago
How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?
Barchart · 13d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.